C. Moore

发表

Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level

C. Moore, M. John, I. James, 2002, Science.

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

C. Moore, I. James, F. Christiansen, 2002, The Lancet.

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

C. Moore, I. James, F. Christiansen, 2005, AIDS.

POPULATION SEQUENCING FROM CHROMATOGRAM DATA

Nebojsa Jojic, D. Heckerman, Simon Mallal, 2007 .

Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation

C. Moore, I. James, S. Mallal, 2006, Journal of Virology.

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

C. Moore, M. John, I. James, 2000, AIDS.

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

C. Moore, I. James, S. Mallal, 2001, AIDS.

Protease inhibitors and nucleoside analogue reverse transcriptase inhibitors interact to cause subcutaneous fat wasting in patients with HIV infection

C. Moore, M. John, I. James, 1999 .

Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8,DR3).

C. Moore, C. Witt, P. Price, 1999, Tissue antigens.

Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

David Heckerman, Sharon Adams, Christian Brander, 2006, Nature Immunology.

Raised lactate levels are common and may be predictive of subcutaneous fat wasting

C. Moore, M. John, I. James, 2000 .

HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1

Philip J. R. Goulder, Todd M. Allen, Simon Mallal, 2005, The Journal of Immunology.

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA

Andrew K. Sewell, Karina Yusim, Bette Korber, 2005, The Journal of experimental medicine.

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

Bette Korber, Michael Bunce, Philip J. R. Goulder, 2004, Nature.

Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution

Christian Brander, Eric S. Rosenberg, Todd M. Allen, 2005, Journal of Virology.

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression

C. Moore, F. Christiansen, C. Witt, 2005, Genes and Immunity.

Response Emergence of a Variant-Specific CTL HIV-1 Viral Escape in Infancy Followed by Altfeld ,

Todd M. Allen, M. Altfeld, B. Walker, 2005 .

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

HLA-DQ 3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

C. Moore, I. James, C. Witt, 2022 .

NK receptor haplotypes and HLA as predictors of HIV-1 progression

C. Moore, F. Christiansen, S. Mallal, 2004 .

NK receptor genes are predictors of HIV progression

C. Moore, I. James, F. Christiansen, 2003 .

Randomized, Controlled, 48‐Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV‐Infected Patients

C. Moore, M. John, I. James, 2003, Journal of acquired immune deficiency syndromes.

Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS

C. Moore, S. Mallal, G. Stewart, 2007, AIDS.

Interactive Selective Pressures of Hla-Restricted Immune Responses and Antiretroviral Drugs on HIV-1

C. Moore, M. John, I. James, 2005, Antiviral therapy.

Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy

C. Moore, M. John, I. James, 2003, AIDS.

Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation

David Nolan, Ian James, Simon Mallal, 2007, Journal of Virology.

Host MHC influences susceptibility to hypersensitivity reactions to two drugs commonly used in HIV therapy

C. Moore, I. James, F. Christiansen, 2005 .